Millennium Management »

Carisma Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $243k 160k 1.52
2023-03-31 $111k 36k 3.11

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Put Option (MSFT)
Amazon Put Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors (TSLA)
Broadcom Put Option (AVGO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices Put Option (AMD)
Merck & Co Call Option (MRK)

View all positions for Millennium Management

Top funds holding Carisma Therapeutics

Vanguard Group
Trustees Of The University Of Pennsylvania
Tpg Gp A
BlackRock
Geode Capital Management
Goldman Sachs Group
Northern Trust
Millennium Management
Jane Street
Renaissance Technologies
State Street Corporation
Y-Intercept
Susquehanna International
Centiva Capital
Bank of America Corporation

View all funds holding Carisma Therapeutics